Sponsors (11)
Introduced December 4, 2025 by Michael F. Bennet · Last progress December 4, 2025
The bill expands federal levers to lower premiums and broaden access—through reinsurance, bigger premium tax credits, stronger antitrust enforcement, and a statutory path to a public plan—while creating meaningful new federal spending, implementation uncertainty, and potential provider and drug‑price trade-offs that could offset or complicate those benefits.
People who buy marketplace coverage (especially low- and moderate-income households) will be eligible for larger premium tax credits and broader eligibility, reducing their monthly premiums and improving affordability.
Individuals with very high medical costs and other individual-market enrollees will face lower out-of-pocket burdens and more stable premiums because a federal reinsurance program pools extreme claim risk and provides $10 billion per year (2028–2030) to support carriers.
Medicare Exchange enrollees will have better access to care and fewer provider refusals because providers must treat these patients on equal terms and noncompliance can lead to exclusion from federal health programs.
Taxpayers could face substantial new federal costs and higher deficits because the bill adds or enables new spending (reinsurance funding, expanded premium tax credits, DOJ/FTC enforcement funding) and creates a potential pathway for a publicly financed plan without specified offsets.
Hospitals, clinics, and other providers may face higher operating and compliance costs, capacity strain, or risk of exclusion (which in some areas could reduce local access), as requirements to accept additional Medicare Exchange patients and stronger enforcement are implemented.
States, insurers, providers, and federal agencies will confront implementation uncertainty and administrative complexity because key substantive rules and coordination details are missing, programs overlap with existing ACA provisions, negotiation processes may be disrupted, and reporting/oversight timelines create transition risk.
Based on analysis of 8 sections of legislative text.
Creates a Medicare-style public plan and reinsurance program, expands premium tax credits and fixes the family glitch, alters Medicare drug negotiation law, and funds antitrust work.
Creates a new public Medicare-style plan (text placeholder inserted), expands financial help for people who buy coverage on the individual market, funds a national reinsurance pool to lower premiums, changes rules about employer-sponsored coverage affordability (fixing the “family glitch”), modifies Medicare prescription drug negotiation law, and provides funding to the DOJ and FTC for health care market studies and antitrust enforcement. It also creates penalties that can exclude providers from federal health programs if they apply patient acceptance or treatment restrictions unequally to enrollees in the new public plan.